2026, doi: 10.1016/j.ebiom.2025.106119 Farokhnia, M., et al, "Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake," Journal of Clinical Investigation, March 6, 2025, doi: 10.1172/JCI188314 Petrie, G.N
In 2024 semaglutide (Wegovy) became the first weight loss drug to also be approved for the reduction of risk of serious cardiovascular events in patients with cardiovascular disease and obesity or overweight
Probiotics, NGPs and fiber supplementations might be successful strategies to increase butyrate-producing bacteria and improve hyperglycemia and insulin resistance, but their effects might be dependent on the individualized gut microbiota at baseline (responders vs
At Allure Esthetic, we offer assistance in seeing if your insurance provider will cover your Ozempic for weight loss medication
Alexander Mueller, Princeton University, United States Updates Copyright 2022 Mayorga-Ramos, Barba-Ostria, Simancas-Racines and Guamn